Addiction Drug Developer Adial Pharmaceuticals Successfully Passes Patent Opposition Period in Europe for AD04 in …
Addiction Drug Developer Adial Pharmaceuticals Successfully Passes Patent Opposition Period in Europe for AD04 in … The Bakersfield Californian Adial Pharmaceuticals (ADIL) Reports ‘No Challenges to European Patent’ for AD04 in Alcohol Use Disorder StreetInsider.com Full coverage